NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,996,773 | -17.0% | 361,509 | -8.7% | 0.31% | -19.2% |
| Q2 2023 | $19,267,900 | +42.1% | 395,970 | +62.1% | 0.38% | +38.2% |
| Q1 2023 | $13,558,928 | +96.3% | 244,217 | +42.0% | 0.28% | +109.9% |
| Q4 2022 | $6,906,749 | +59.9% | 171,938 | +74.4% | 0.13% | +14.9% |
| Q3 2022 | $4,319,000 | -20.4% | 98,571 | -35.7% | 0.11% | -53.1% |
| Q2 2022 | $5,429,000 | -24.8% | 153,198 | -13.7% | 0.24% | -23.6% |
| Q1 2022 | $7,218,000 | +871.5% | 177,435 | +2560.2% | 0.32% | +511.5% |
| Q3 2021 | $743,000 | -71.7% | 6,670 | -71.1% | 0.05% | -83.6% |
| Q2 2021 | $2,623,000 | – | 23,101 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |